The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)

Volume 15, 2 Issues, 2017

Download PDF Flyer

Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases

Anti-Infective Agents, 8(2): 87-101.

Author(s): Brett D. Shepard and Andrew D Badley.

Affiliation: Mayo Clinic College of Medicine, Division of Infectious Diseases, Rochester, MN, 55905, USA.


TNF-related apoptosis inducing ligand (TRAIL) is a key mediator of the innate immune response to infection. While TRAIL-mediated apoptosis plays an essential role in the clearance of virus-infected cells, its physiologic role also includes immunosurveilance for cancer cells. Therapeutics that induce TRAIL-mediated apoptosis in cancer cells remain a focus of ongoing investigation in clinical trials, and much has been learned from these studies regarding the efficacy and toxicity of these interventions. These data, combined with data from numerous preclinical studies that detail the important and multifaceted role of TRAIL during infection with human immunodeficiency virus and other viruses, suggest that therapeutic exploitation of TRAIL signaling offers a novel and efficacious strategy for the management of infectious diseases.


Infectious Diseases, TNF, apoptosis, ligand (TRAIL), cancer cells.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 8
Issue Number: 2
First Page: 87
Last Page: 101
Page Count: 15
DOI: 10.2174/187152109787846060
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science